JHS Svendgaard Laboratories (BOM:532771) Debt-to-Equity : 0.03 (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is JHS Svendgaard Laboratories Debt-to-Equity?

JHS Svendgaard Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹39.6 Mil. JHS Svendgaard Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹11.7 Mil. JHS Svendgaard Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹1,698.8 Mil. JHS Svendgaard Laboratories's debt to equity for the quarter that ended in Mar. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for JHS Svendgaard Laboratories's Debt-to-Equity or its related term are showing as below:

BOM:532771' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.04 Max: 0.16
Current: 0.03

During the past 13 years, the highest Debt-to-Equity Ratio of JHS Svendgaard Laboratories was 0.16. The lowest was 0.01. And the median was 0.04.

BOM:532771's Debt-to-Equity is ranked better than
99.94% of 1650 companies
in the Consumer Packaged Goods industry
Industry Median: 0.4 vs BOM:532771: 0.03

JHS Svendgaard Laboratories Debt-to-Equity Historical Data

The historical data trend for JHS Svendgaard Laboratories's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JHS Svendgaard Laboratories Debt-to-Equity Chart

JHS Svendgaard Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.05

0.04

0.03

0.10

0.03

JHS Svendgaard Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.10	N/A	0.01	N/A	0.03

Competitive Comparison of JHS Svendgaard Laboratories's Debt-to-Equity

For the Household & Personal Products subindustry, JHS Svendgaard Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JHS Svendgaard Laboratories's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JHS Svendgaard Laboratories's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where JHS Svendgaard Laboratories's Debt-to-Equity falls into.

JHS Svendgaard Laboratories Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

JHS Svendgaard Laboratories's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(39.613	+	11.674)	/	1698.839
	=	0.03

JHS Svendgaard Laboratories's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(39.613	+	11.674)	/	1698.839
	=	0.03

JHS Svendgaard Laboratories (BOM:532771) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

JHS Svendgaard Laboratories Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of JHS Svendgaard Laboratories's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

JHS Svendgaard Laboratories (BOM:532771) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JHS Svendgaard Laboratories Ltd (BOM:532771) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

JHS:India

Address

Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044

Website

https://www.svendgaard.com

JHS Svendgaard Laboratories Ltd is a manufacturer of dental and oral care products. Its business segments include Manufacturing Business; Other than Manufacturing Business and Retail Business. Its product portfolio includes a toothbrush, toothpaste, mouthwash, laundry detergent, hand sanitizer, and room fresheners. It sells products under its own brand name and private labels including Dr. Gold, P&G, Amway, Future Group, Dabur, Elder Pharma, J. L. Morison's among others, and in the international market are - Dr. Fresh, Boots, Peanuts, and Lavoris. It generates the majority of the revenue from the Manufacturing Business segment.

JHS Svendgaard Laboratories (BOM:532771) Headlines

No Headlines